Introduction
Modern non-ionic low osmolar contrast media are relatively safe and produce good quality angiographic images. However, their use is not entirely free from problems in certain situations. Nephrotoxicity is a well recognized side effect of intravascular contrast. The risk of renal damage is particularly high in patients with diabetes, hypertension, dehydration, multiple myeloma and in the presence of impaired renal function; 1 conditions which often co-exist with peripheral vascular disease. The risk of allergic reaction to iodine containing contrast has been estimated to be 4-7% in atopic individuals, 2 rising to 38% in those with a previous history of adverse reaction to contrast. 3 Rapid injection of contrast can result in pulmonary oedema particularly in patients with poor ventricular function. 4 Carbon dioxide has been used successfully in the past as a negative contrast for cystogram, s arthrogram 6 and angiogram. 7"s In the present study CO2 has been evaluated in a prospective controlled study as an angiographic contrast medium during digital subtraction peripheral angiography. Twelve examinations were performed on 11 patients with a median age of 72 years (range 67-82 years). All the patients were being investigated for peripheral vascular disease. Approval was obtained from the University Hospital Ethics Committee and informed consent was obtained from the patients. Angiography was performed with both Iopamidol (Niopam, E. Merck Ltd) and Carbon dioxide in 9/12 procedures and CO2 was used alone in three examinations. Of these three procedures two were performed in a patient with a history of severe adverse reaction to iodinated contrast and another patient had refractory cardiac failure. Anterior femoral wall puncture technique was used for the introduction of a 5 F angiographic flush catheter. Iopamidol injections were carried out with the catheter in the abdominal aorta. For CO2 injections the catheter was withdrawn into the external iliac and direct intra-aortic injection was avoided. Medical grade CO2 (BOC Medical gases, Guildford, Surrey U.K.) was drawn into a 60 ml syringe from a laparoscopic insuffiator. The syringe was flushed with CO2 a few times to eliminate any air and ipsilateral images were obtained following rapid hand injection of 50 ml of CO2 for each run. The leg was elevated approximately 20 ° to facilitate the forward flow of CO2 aided by buoyancy. Arterial blood gases were obtained before and within i min of completion of the study in 10/12 cases and analysed for pH, PaCO~. and PaO2 on a blood gas analyser. Paired images obtained with Niopam and CO2 were blindly assessed by MJH (a vascular radiologist from another region) without any knowledge of the nature of the study. He was asked to select the better image in each pair and using it as the standard, grade individual vessels in the other image as adequate or inadequate on the criteria that no important clinical information was missing or misinformation was present. Statistical analysis was performed by using Wilcoxon paired rank signed test for comparing the changes in arterial blood before and after the procedure. images were deemed to be inadequate. Of these 6% were iliac and 17% were tibial images. (6) Bilateral superficial femoral angioplasties were performed on two separate occasions on one patient who had a history of major adverse reaction to iodinated contrast with good radiological, haemodynamic and clinical result (Fig.  4) . (7) One diagnostic examination was successfully carried out with a 20 G cannula placed in the femoral artery.
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Carbon dioxide (CO2) has been used as a radiological contrast medium for more than three decades. 5 As an angiographic contrast medium CO2 has been in use since 1968 by Bendib et al. 7 who has reported uncomplicated use of intravenous CO2 in more than 1600 patients for diagnostic study of the right side of the heart. In patients with peripheral vascular disease CO2 was first used intra-arterially as a vasodilator agent by Bartley et al. 9 more than 20 years ago. During subsequent study on therapeutic use of CO2 in patients with peripheral occlusive arterial disease by the same group, 1° it was observed that CO2 delineated the artery by acting as a negative radiological contrast.
Since then Hawkins and Herrera s have reported safe use of COz for angiography in more than 300 patients. However, in Europe the use of CO2 as a contrast medium for peripheral angiography has not been widely reported. Moreover, the quality of images obtained during peripheral digital subtraction arteriography using CO2 and non-ionic iodinated contrast has not been compared in the past. The important risk factors related to contrast medium induced renal damage are pre-existing renal insufficiency, diabetes mellitus with the risk becoming more significant in patients with diabetic nephropathy. In a prospective study of non diabetic patients with impaired renal function undergoing intravenous urography (IVU) the incidence of acute renal failure has been reported to be as high as 62%. 12 Patients undergoing IVU are more likely to have impaired renal function than those undergoing arteriography but the volume of contrast used for peripheral angiography is nearly three to four times greater than the volume used for IVU and there is some suggestion that the nephrotoxicity may be dose related. CO2 could therefore be used as an alternative for arteriography in patients with impaired renal function, diabetic nephropathy and multiple myeloma who are at an increased risk of contrast induced renal damage. The iodine load following injection of 100 ml of triiodinated non ionic contrast medium could be 3-4 g. This could produce hyperthyroidism in euthyroid Ca) (b) which is almost 400 times less than the conventional mono acid monomeric salt contrast medium. 1° This means that angiography can be performed via relatively fine catheters and small puncture in the femoral artery. In the present study we were able to perform the procedure with a 20 G cannula (Viggo, Spectramed) instead of the standard 4 or 5 F catheter. Because there is some evidence from animal studies that CO2 may be neurotoxic, 14 we avoided direct aortic injection to avoid any adverse effect on the spinal cord. The visualisation of the proximal iliac was therefore dependent upon reflux of the CO2 and could account for the 6% of the inadequate images being in the iliac region (Fig. 5a ). It seems likely that antegrade filling of the iliac artery from aortic injection would overcome this problem. Of the inadequate images 17% were in the tibial region. In some studies fragmentation of the column of CO 2 was seen in the tibial vessel (Fig. 5a ). It appears to be related to slow transit in patients with poor ventricular function. However, the visualisation of tibial vessels was not a consistent problem and good images were also obtained (Fig.   6 ).
Cost is an important consideration. A cylinder of COz containing 450 1 of medical grade CO2 costs less than 100 ml of non-ionic contrast. In other words, the contrast cost of angiography with non-ionic contrast is 1000 fold greater than CO2. However, the overall cost benefit may not be a significant one if CO2 is used only selectively in a relatively small number of patients at an increased risk of adverse reaction to iodinated intravascular contrast.
In the present study no complication was encountered and no significant changes were observed in the arterial pH and gases. This is somewhat expected since the volume of COz used for each study was close to the amount excreted by the body each minute at rest. C02 injection not only enabled diagnostic angiography but angioplasty was also performed in a patient with bilateral SFA stenosis who had a major adverse reaction to iodinated contrast in the past. Duplex scan guided angioplasty which requires two operators is another technique that can enable angil"oplasty without the use of intravascular contrast.
With further experience it may provide another safe alternative for localised studies and angioplasty.
In summary, COa is safe and effective as a contrast medium during peripheral angiography with digital subtraction imaging. It could be used as an alternative in patients with history of adverse reaction to iodinated contrast and those individuals who are at an increased risk of renal damage and pulmonary oedema from the conventional intravascular contrast.
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